Innoviva, Inc. (INVA)
USD 17.5
(-3.21%)
USD 17.5
(-3.21%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 568.55 Million USD | -14.59% |
| 2022 | 665.7 Million USD | 66.24% |
| 2021 | 400.46 Million USD | 2.23% |
| 2020 | 391.73 Million USD | 2.36% |
| 2019 | 382.71 Million USD | -1.65% |
| 2018 | 389.14 Million USD | -36.21% |
| 2017 | 610.04 Million USD | -16.66% |
| 2016 | 731.98 Million USD | -4.53% |
| 2015 | 766.71 Million USD | 2.91% |
| 2014 | 745 Million USD | 94.96% |
| 2013 | 382.13 Million USD | 78.94% |
| 2012 | 213.55 Million USD | -38.25% |
| 2011 | 345.83 Million USD | -2.2% |
| 2010 | 353.62 Million USD | -4.53% |
| 2009 | 370.38 Million USD | -0.19% |
| 2008 | 371.1 Million USD | 62.59% |
| 2007 | 228.24 Million USD | 14.63% |
| 2006 | 199.11 Million USD | 20.49% |
| 2005 | 165.25 Million USD | 72.76% |
| 2004 | 95.65 Million USD | -77.49% |
| 2003 | 425.01 Million USD | 0.09% |
| 2002 | 424.64 Million USD | 0.0% |
| 2000 | 22.66 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 559.4 Million USD | -0.8% |
| 2024 Q1 | 563.93 Million USD | -0.81% |
| 2023 Q1 | 568.27 Million USD | -14.64% |
| 2023 FY | 568.55 Million USD | -14.59% |
| 2023 Q2 | 563.15 Million USD | -0.9% |
| 2023 Q3 | 560.61 Million USD | -0.45% |
| 2023 Q4 | 568.55 Million USD | 1.42% |
| 2022 Q3 | 686.34 Million USD | 19.95% |
| 2022 Q2 | 572.17 Million USD | 3.05% |
| 2022 Q4 | 665.7 Million USD | -3.01% |
| 2022 Q1 | 555.25 Million USD | 38.65% |
| 2022 FY | 665.7 Million USD | 66.24% |
| 2021 FY | 400.46 Million USD | 2.23% |
| 2021 Q1 | 391.6 Million USD | -0.03% |
| 2021 Q2 | 395.4 Million USD | 0.97% |
| 2021 Q3 | 395.43 Million USD | 0.01% |
| 2021 Q4 | 400.46 Million USD | 1.27% |
| 2020 Q4 | 391.73 Million USD | 1.12% |
| 2020 Q3 | 387.38 Million USD | 0.15% |
| 2020 Q2 | 386.8 Million USD | 1.22% |
| 2020 Q1 | 382.14 Million USD | -0.15% |
| 2020 FY | 391.73 Million USD | 2.36% |
| 2019 Q1 | 390.17 Million USD | 0.26% |
| 2019 FY | 382.71 Million USD | -1.65% |
| 2019 Q2 | 395.6 Million USD | 1.39% |
| 2019 Q3 | 392.19 Million USD | -0.86% |
| 2019 Q4 | 382.71 Million USD | -2.42% |
| 2018 FY | 389.14 Million USD | -36.21% |
| 2018 Q4 | 389.14 Million USD | 0.82% |
| 2018 Q1 | 489.49 Million USD | -19.76% |
| 2018 Q2 | 494.05 Million USD | 0.93% |
| 2018 Q3 | 385.96 Million USD | -21.88% |
| 2017 Q3 | 613.93 Million USD | -8.2% |
| 2017 Q1 | 726.05 Million USD | -0.81% |
| 2017 FY | 610.04 Million USD | -16.66% |
| 2017 Q4 | 610.04 Million USD | -0.63% |
| 2017 Q2 | 668.75 Million USD | -7.89% |
| 2016 Q2 | 741.21 Million USD | -1.15% |
| 2016 FY | 731.98 Million USD | -4.53% |
| 2016 Q4 | 731.98 Million USD | -0.87% |
| 2016 Q3 | 738.4 Million USD | -0.38% |
| 2016 Q1 | 749.79 Million USD | -2.21% |
| 2015 FY | 766.71 Million USD | 2.91% |
| 2015 Q4 | 766.71 Million USD | 0.8% |
| 2015 Q3 | 760.63 Million USD | 0.6% |
| 2015 Q2 | 756.07 Million USD | 0.97% |
| 2015 Q1 | 748.84 Million USD | 0.52% |
| 2014 Q3 | 746.84 Million USD | -5.84% |
| 2014 FY | 745 Million USD | 94.96% |
| 2014 Q4 | 745 Million USD | -0.25% |
| 2014 Q1 | 341.78 Million USD | -10.56% |
| 2014 Q2 | 793.13 Million USD | 132.06% |
| 2013 Q4 | 382.13 Million USD | 13.74% |
| 2013 Q2 | 509.05 Million USD | 1.81% |
| 2013 Q1 | 500 Million USD | 134.14% |
| 2013 Q3 | 335.96 Million USD | -34.0% |
| 2013 FY | 382.13 Million USD | 78.94% |
| 2012 FY | 213.55 Million USD | -38.25% |
| 2012 Q1 | 211.59 Million USD | -38.82% |
| 2012 Q4 | 213.55 Million USD | 1.38% |
| 2012 Q2 | 210.16 Million USD | -0.68% |
| 2012 Q3 | 210.65 Million USD | 0.23% |
| 2011 Q3 | 342.47 Million USD | 0.55% |
| 2011 FY | 345.83 Million USD | -2.2% |
| 2011 Q1 | 342.92 Million USD | -3.02% |
| 2011 Q2 | 340.6 Million USD | -0.68% |
| 2011 Q4 | 345.83 Million USD | 0.98% |
| 2010 Q4 | 353.62 Million USD | -0.03% |
| 2010 FY | 353.62 Million USD | -4.53% |
| 2010 Q3 | 353.72 Million USD | -1.31% |
| 2010 Q2 | 358.4 Million USD | -1.25% |
| 2010 Q1 | 362.95 Million USD | -2.01% |
| 2009 Q4 | 370.38 Million USD | 3.26% |
| 2009 FY | 370.38 Million USD | -0.19% |
| 2009 Q1 | 359.05 Million USD | -3.25% |
| 2009 Q2 | 365.54 Million USD | 1.81% |
| 2009 Q3 | 358.68 Million USD | -1.88% |
| 2008 Q3 | 380.41 Million USD | -3.21% |
| 2008 FY | 371.1 Million USD | 62.59% |
| 2008 Q1 | 390.1 Million USD | 70.92% |
| 2008 Q4 | 371.1 Million USD | -2.45% |
| 2008 Q2 | 393.01 Million USD | 0.75% |
| 2007 Q1 | 227.31 Million USD | 14.16% |
| 2007 FY | 228.24 Million USD | 14.63% |
| 2007 Q4 | 228.24 Million USD | -4.7% |
| 2007 Q3 | 239.5 Million USD | 7.02% |
| 2007 Q2 | 223.8 Million USD | -1.54% |
| 2006 FY | 199.11 Million USD | 20.49% |
| 2006 Q4 | 199.11 Million USD | 0.4% |
| 2006 Q3 | 198.31 Million USD | 2.6% |
| 2006 Q2 | 193.29 Million USD | 13.82% |
| 2006 Q1 | 169.81 Million USD | 2.76% |
| 2005 Q4 | 165.25 Million USD | 67.24% |
| 2005 Q2 | 99.84 Million USD | 1.76% |
| 2005 FY | 165.25 Million USD | 72.76% |
| 2005 Q3 | 98.81 Million USD | -1.03% |
| 2005 Q1 | 98.11 Million USD | 2.57% |
| 2004 Q4 | 95.65 Million USD | -1.26% |
| 2004 Q2 | 91.7 Million USD | 0.0% |
| 2004 Q3 | 96.87 Million USD | 5.64% |
| 2004 FY | 95.65 Million USD | -77.49% |
| 2003 FY | 425.01 Million USD | 0.09% |
| 2002 FY | 424.64 Million USD | 0.0% |
| 2000 FY | 22.66 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -69.325% |
| Alkermes plc | 933.53 Million USD | 39.097% |
| Agenus Inc. | 462.29 Million USD | -22.985% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 85.963% |
| Aptorum Group Limited | 5.25 Million USD | -10715.681% |
| Ardelyx, Inc. | 130.76 Million USD | -334.796% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -18.847% |
| Bicycle Therapeutics plc | 224.41 Million USD | -153.352% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -336.642% |
| ChromaDex Corporation | 26.5 Million USD | -2044.832% |
| Chimerix, Inc. | 19.74 Million USD | -2779.473% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1516.255% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -683.486% |
| CRISPR Therapeutics AG | 346.76 Million USD | -63.957% |
| Precision BioSciences, Inc. | 140.92 Million USD | -303.457% |
| Dyadic International, Inc. | 2.34 Million USD | -24190.336% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -3395.985% |
| Fortress Biotech, Inc. | 165.93 Million USD | -242.627% |
| Lantern Pharma Inc. | 2.73 Million USD | -20652.481% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -695.4% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -16012.108% |
| Incyte Corporation | 1.59 Billion USD | 64.293% |
| IO Biotech, Inc. | 17.55 Million USD | -3138.505% |
| Jaguar Health, Inc. | 45.86 Million USD | -1139.594% |
| Novavax, Inc. | 2.57 Billion USD | 77.897% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1476.771% |
| Opthea Limited | 264.6 Million USD | -114.871% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -334.982% |
| ContextLogic Inc. | 206 Million USD | -175.996% |
| MiMedx Group, Inc. | 96.33 Million USD | -490.213% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -1083.941% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -16011.369% |
| NextCure, Inc. | 14.99 Million USD | -3691.105% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -13966.106% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -8415.082% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -1116.44% |
| Vaxcyte, Inc. | 167.44 Million USD | -239.537% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1609.461% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -141.717% |
| Pharming Group N.V. | 244.07 Million USD | -132.943% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -4668.931% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -344.908% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -8504.934% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -8504.934% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -589.714% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -8458.663% |
| Acelyrin, Inc. | 86.35 Million USD | -558.404% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -43660.319% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -3854.044% |
| Summit Therapeutics Inc. | 125.25 Million USD | -353.908% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -5898.017% |
| Senti Biosciences, Inc. | 52.57 Million USD | -981.494% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -726.66% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -275.252% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -28967.076% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -42470.18% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -150.649% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -5969.734% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -149.973% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -14.973% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -5109.382% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -1966.635% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -4596.953% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -16.842% |
| Immix Biopharma, Inc. | 3.72 Million USD | -15176.334% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -1403.628% |
| MEI Pharma, Inc. | 8.35 Million USD | -6704.931% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1859.511% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -63.574% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -289.769% |
| Fortress Biotech, Inc. | 165.93 Million USD | -242.627% |
| Precigen, Inc. | 41.64 Million USD | -1265.268% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -1038.698% |
| AlloVir, Inc. | 45.01 Million USD | -1163.028% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -336.217% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -312.592% |
| ImmuCell Corporation | 18.81 Million USD | -2921.798% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -1914.285% |
| Onconetix, Inc. | 23.18 Million USD | -2352.676% |
| PureTech Health plc | 125.58 Million USD | -352.73% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -6252.536% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1558.456% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -23153.661% |
| Seer, Inc. | 39.36 Million USD | -1344.308% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -819.481% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -1988.115% |
| ESSA Pharma Inc. | 3.49 Million USD | -16167.252% |
| GlycoMimetics, Inc. | 6.9 Million USD | -8137.408% |
| GT Biopharma, Inc. | 6.63 Million USD | -8471.566% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -115.043% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -108.806% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -576.638% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -5716.984% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -1992.65% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -17525.295% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -670.74% |
| Aptose Biosciences Inc. | 15.8 Million USD | -3496.45% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -5050.074% |
| Soligenix, Inc. | 7.27 Million USD | -7715.251% |
| Century Therapeutics, Inc. | 175.94 Million USD | -223.149% |
| Kura Oncology, Inc. | 51.66 Million USD | -1000.523% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -368.785% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -13656.4% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -8496.378% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -125.082% |
| Autolus Therapeutics plc | 263.9 Million USD | -115.436% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -5324.079% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -539.822% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -1112.29% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -61.129% |
| GRI Bio, Inc. | 2.69 Million USD | -20980.905% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -70127.586% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1728.671% |
| IGM Biosciences, Inc. | 220.17 Million USD | -158.225% |
| INmune Bio, Inc. | 18.86 Million USD | -2914.272% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -121.676% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2034.059% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -20814.904% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -17232.497% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -872.632% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -491.262% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -114.763% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 30.92% |
| Verastem, Inc. | 71.18 Million USD | -698.696% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -1056.157% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -1373.773% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -1061.923% |
| Histogen Inc. | 5.69 Million USD | -9879.849% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -12864.049% |
| Surrozen, Inc. | 8.14 Million USD | -6880.381% |
| Organovo Holdings, Inc. | 2.74 Million USD | -20589.665% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -181049.437% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -911.12% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -3343.266% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -1012.561% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -68659.123% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -348.65% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -5157.754% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -276.801% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -21705.783% |
| Apollomics, Inc. | 14.15 Million USD | -3917.184% |
| Amarin Corporation plc | 279.58 Million USD | -103.354% |
| Mesoblast Limited | 188.79 Million USD | -201.143% |
| Turnstone Biologics Corp. | 14.14 Million USD | -3918.603% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -214.485% |
| Synaptogenix, Inc. | 5.52 Million USD | -10182.217% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -8452.226% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -234.23% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -6544.141% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -32252.012% |
| Exelixis, Inc. | 678.44 Million USD | 16.198% |
| Better Therapeutics, Inc. | 23.84 Million USD | -2284.666% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -246.581% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 4.318% |
| NLS Pharmaceutics AG | 10.68 Million USD | -5223.419% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -34917.64% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -1360.56% |
| Gritstone bio, Inc. | 125.91 Million USD | -351.522% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3774.026% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -11072.994% |
| Avid Bioservices, Inc. | 275.66 Million USD | -106.245% |
| Insmed Incorporated | 1.66 Billion USD | 65.786% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -7289.527% |
| MediWound Ltd. | 27.18 Million USD | -1991.264% |
| OmniAb, Inc. | 87.4 Million USD | -550.517% |
| Alector, Inc. | 487.66 Million USD | -16.586% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -40.92% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -2985.764% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -1381.646% |
| Zai Lab Limited | 240.17 Million USD | -136.722% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 9.762% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1845.297% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -497.991% |
| Immunic, Inc. | 25.36 Million USD | -2141.217% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -721.18% |
| Veracyte, Inc. | 93.71 Million USD | -506.656% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -21628.049% |
| FibroGen, Inc. | 585.72 Million USD | 2.932% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3170.736% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -86957.555% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -9953.156% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 92.574% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -6835.253% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -576.67% |
| TG Therapeutics, Inc. | 169.08 Million USD | -236.252% |
| Galecto, Inc. | 5.89 Million USD | -9543.012% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -6763.254% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 78.286% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1872.632% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -4404.809% |
| XBiotech Inc. | 8.39 Million USD | -6670.894% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3774.026% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -969.109% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -56.58% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -2014.834% |
| Theravance Biopharma, Inc. | 169 Million USD | -236.413% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 53.229% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -13.614% |
| Vaxxinity, Inc. | 30.94 Million USD | -1737.358% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 41.536% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -9326.992% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 23.708% |
| NexImmune, Inc. | 5.08 Million USD | -11082.653% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -152985.941% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -18390.41% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 92.0% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -10931.212% |
| Scopus BioPharma Inc. | 7.45 Million USD | -7527.031% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -2062.288% |
| Ainos, Inc. | 7.39 Million USD | -7589.138% |
| Pluri Inc. | 34.11 Million USD | -1566.721% |
| Prothena Corporation plc | 135.01 Million USD | -321.097% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -133.873% |
| Celularity Inc. | 102.92 Million USD | -452.373% |
| Rallybio Corporation | 9.43 Million USD | -5925.35% |
| Cue Biopharma, Inc. | 24.44 Million USD | -2225.842% |
| MeiraGTx Holdings plc | 319.99 Million USD | -77.677% |
| Omeros Corporation | 403.25 Million USD | -40.992% |
| Humacyte, Inc. | 114.67 Million USD | -395.786% |
| Immunocore Holdings plc | 228.15 Million USD | -149.192% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -11562.605% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -640.881% |
| Blueprint Medicines Corporation | 918.64 Million USD | 38.109% |
| CalciMedica, Inc. | 4.02 Million USD | -14014.995% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -3157.804% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -268.847% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -562.517% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -104.668% |
| Pulmatrix, Inc. | 15.96 Million USD | -3461.686% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -3504.59% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -2210.623% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -126.688% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -1019.505% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 53.037% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -1688.856% |
| Nutriband Inc. | 1.07 Million USD | -52596.449% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -5247.052% |
| Vor Biopharma Inc. | 59.1 Million USD | -861.952% |
| Roivant Sciences Ltd. | 773.95 Million USD | 26.539% |
| Evogene Ltd. | 17.99 Million USD | -3060.378% |
| ProKidney Corp. | 29.21 Million USD | -1846.03% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -689.886% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -80547.618% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 69.901% |
| CorMedix Inc. | 11.91 Million USD | -4670.721% |
| BioLineRx Ltd. | 50.7 Million USD | -1021.36% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -280.407% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -542.86% |
| Atai Life Sciences N.V. | 49.16 Million USD | -1056.487% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1725.072% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -3065.305% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -356.17% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -9955.748% |
| MediciNova, Inc. | 3.89 Million USD | -14509.9% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -3010.411% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -37696.603% |
| GeoVax Labs, Inc. | 3.51 Million USD | -16052.592% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -43.119% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1752.564% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 79.111% |
| Mereo BioPharma Group plc | 15.96 Million USD | -3461.91% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1722.224% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -868.836% |
| Absci Corporation | 58.3 Million USD | -875.151% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2884.838% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1673.289% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -670.5% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -549.9% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1583.601% |
| Allakos Inc. | 74.79 Million USD | -660.167% |
| Imunon, Inc. | 8.53 Million USD | -6564.989% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -2426.785% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -395.203% |
| BioAtla, Inc. | 48.98 Million USD | -1060.642% |
| NLS Pharmaceutics AG | 10.68 Million USD | -5223.419% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -20358.87% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -335.325% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -3899.662% |
| XOMA Corporation | 145.58 Million USD | -290.543% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1588.852% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -726.876% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1699.386% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -819.645% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -1164.432% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -1074.646% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -19710.174% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -6869.242% |
| Akari Therapeutics, Plc | 4.58 Million USD | -12302.967% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3106.157% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 65.531% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -140662.748% |
| UroGen Pharma Ltd. | 243.52 Million USD | -133.47% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -77.071% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -20488.088% |
| Orgenesis Inc. | 35.53 Million USD | -1499.977% |
| Entera Bio Ltd. | 1.37 Million USD | -41129.297% |
| GH Research PLC | 6.7 Million USD | -8384.584% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -8261.059% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -2920.036% |
| Xencor, Inc. | 283.55 Million USD | -100.506% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -18942.662% |
| Replimune Group, Inc. | 113.21 Million USD | -402.192% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -15032.635% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -449.166% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -140662.748% |
| Portage Biotech Inc. | 4.45 Million USD | -12676.449% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -37696.603% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -2366.603% |
| OncoCyte Corporation | 49.29 Million USD | -1053.296% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -13643.747% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -71193.217% |
| Purple Biotech Ltd. | 10 Million USD | -5582.679% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -9726.339% |
| scPharmaceuticals Inc. | 57.26 Million USD | -892.913% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -4489.53% |
| HilleVax, Inc. | 78.9 Million USD | -620.516% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -11158.455% |
| Tharimmune, Inc. | 1.81 Million USD | -31224.385% |
| Genprex, Inc. | 3.25 Million USD | -17371.286% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -1996.508% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -10758.518% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -275896.117% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -158470.68% |
| OKYO Pharma Limited | 7.42 Million USD | -7561.552% |
| Savara Inc. | 37.19 Million USD | -1428.694% |
| Curis, Inc. | 57.61 Million USD | -886.864% |
| Daré Bioscience, Inc. | 26.32 Million USD | -2059.343% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1350.395% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -39273.407% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -2630.928% |
| BeiGene, Ltd. | 2.23 Billion USD | 74.547% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -2570.537% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -116.676% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -2572.52% |
| Erasca, Inc. | 78.61 Million USD | -623.247% |
| bluebird bio, Inc. | 424.62 Million USD | -33.895% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -86668.449% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 69.919% |
| DBV Technologies S.A. | 42.8 Million USD | -1228.393% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -86668.449% |
| Moderna, Inc. | 4.57 Billion USD | 87.564% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -8027.977% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -34232.85% |
| Molecular Templates, Inc. | 31.17 Million USD | -1723.977% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -3230.709% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 3.324% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -356.65% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -1972.209% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -1459.557% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -921.932% |
| MacroGenics, Inc. | 154.2 Million USD | -268.694% |
| RenovoRx, Inc. | 4.46 Million USD | -12630.676% |
| Adicet Bio, Inc. | 37.12 Million USD | -1431.659% |
| Prime Medicine, Inc. | 60.78 Million USD | -835.426% |
| Aditxt, Inc. | 28.53 Million USD | -1892.713% |
| Adagene Inc. | 45.16 Million USD | -1158.712% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -314536.886% |
| Quantum-Si incorporated | 26.63 Million USD | -2034.925% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 18.495% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -18587.382% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -394.561% |
| SciSparc Ltd. | 1.59 Million USD | -35545.893% |
| Vericel Corporation | 127.7 Million USD | -345.207% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -10116.762% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -566.079% |
| Generation Bio Co. | 171.63 Million USD | -231.266% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -4822.528% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -1259.164% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -124.993% |
| Invivyd, Inc. | 51.71 Million USD | -999.437% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -518.146% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -8639.893% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -653.089% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -55585.798% |
| 2seventy bio, Inc. | 310.12 Million USD | -83.329% |
| ADMA Biologics, Inc. | 193.97 Million USD | -193.104% |
| Clene Inc. | 38.95 Million USD | -1359.66% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1473.504% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -121.247% |
| GeoVax Labs, Inc. | 3.51 Million USD | -16052.592% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -198.824% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -4568.044% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -186.681% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -4562.249% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -1081.751% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -975.968% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -53.723% |
| Evaxion Biotech A/S | 17.61 Million USD | -3127.204% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -253.294% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -271.151% |
| Trevena, Inc. | 48.26 Million USD | -1078.053% |
| Surrozen, Inc. | 8.14 Million USD | -6880.381% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -2532.795% |
| Cingulate Inc. | 10.36 Million USD | -5387.495% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -20574.618% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -1424.595% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -15752.47% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -4223.589% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -79.24% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -2188.028% |
| Clearmind Medicine Inc. | 3.61 Million USD | -15649.328% |
| Kronos Bio, Inc. | 54.2 Million USD | -948.97% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -1108.579% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2398.061% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -2732.704% |
| Statera Biopharma, Inc. | 22.67 Million USD | -2407.235% |
| ImmunityBio, Inc. | 1.09 Billion USD | 47.858% |
| Korro Bio, Inc. | 51.75 Million USD | -998.609% |
| Kineta, Inc. | 7.22 Million USD | -7772.501% |
| BioVie Inc. | 9.7 Million USD | -5760.074% |
| Codexis, Inc. | 49.94 Million USD | -1038.333% |
| Celularity Inc. | 102.92 Million USD | -452.373% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -490.722% |
| Celcuity Inc. | 51.45 Million USD | -1005.056% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -164605.064% |
| Cibus, Inc. | 206.11 Million USD | -175.839% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -1238.557% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -2058.594% |
| IN8bio, Inc. | 8.77 Million USD | -6381.441% |
| Kodiak Sciences Inc. | 213.59 Million USD | -166.187% |
| Annexon, Inc. | 47.11 Million USD | -1106.656% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -534.963% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -489.956% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -4053.349% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 78.161% |
| Eyenovia, Inc. | 19.78 Million USD | -2774.337% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -221.06% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -7302.057% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -2259.235% |
| Arcellx, Inc. | 339.75 Million USD | -67.343% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -4678.551% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -131.552% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -5845.331% |
| Moolec Science SA | 13.94 Million USD | -3976.999% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -1217.557% |
| Geron Corporation | 146.12 Million USD | -289.081% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -1025.133% |
| Royalty Pharma plc | 6.29 Billion USD | 90.972% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1329.385% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -193018.347% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -23009.221% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -200.573% |
| Humacyte, Inc. | 114.67 Million USD | -395.786% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1857.082% |
| 89bio, Inc. | 59.96 Million USD | -848.171% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -2048.479% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -47437.793% |
| Genelux Corporation | 8.42 Million USD | -6652.399% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -8192.765% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -317.075% |
| Notable Labs, Ltd. | 4.42 Million USD | -12742.828% |
| Liquidia Corporation | 73.13 Million USD | -677.369% |
| Mustang Bio, Inc. | 17.61 Million USD | -3126.925% |
| Immunovant, Inc. | 48.95 Million USD | -1061.377% |
| Quantum-Si incorporated | 26.63 Million USD | -2034.925% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -1381.26% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -18222.655% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -669.759% |
| Acasti Pharma Inc. | 11.55 Million USD | -4819.547% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -2414.857% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -20814.904% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -1441.752% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -41618.116% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -9226.64% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -2189.317% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -2352.346% |
| PepGen Inc. | 34.63 Million USD | -1541.743% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -4581.752% |
| United Therapeutics Corporation | 1.18 Billion USD | 51.907% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -8040.779% |
| Solid Biosciences Inc. | 38.45 Million USD | -1378.371% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -6544.141% |
| Immuneering Corporation | 12 Million USD | -4634.637% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -181049.437% |
| Silo Pharma, Inc. | 1.56 Million USD | -36130.349% |
| Belite Bio, Inc | 4.21 Million USD | -13401.591% |
| XOMA Corporation | 145.58 Million USD | -290.543% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -23316.474% |
| Bionomics Limited | 10.15 Million USD | -5496.689% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -2545.535% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2381.351% |
| uniQure N.V. | 624.01 Million USD | 8.889% |
| Cassava Sciences, Inc. | 14.19 Million USD | -3905.298% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -314536.886% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -234.081% |
| Forte Biosciences, Inc. | 3.66 Million USD | -15408.783% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -218084.609% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -8326.738% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -7302.057% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3170.736% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -5279.939% |
| Altimmune, Inc. | 16.54 Million USD | -3337.229% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 7.958% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2381.351% |
| Compugen Ltd. | 55.77 Million USD | -919.367% |
| Peak Bio, Inc. | 20.75 Million USD | -2639.565% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -414.699% |
| Benitec Biopharma Inc. | 4.96 Million USD | -11358.122% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -260.201% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -656.315% |
| Zura Bio Limited | 21.29 Million USD | -2570.261% |
| PolyPid Ltd. | 17.46 Million USD | -3154.82% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -405.834% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -656.315% |
| Instil Bio, Inc. | 99.8 Million USD | -469.686% |
| argenx SE | 444.95 Million USD | -27.779% |
| Immunome, Inc. | 28.65 Million USD | -1883.921% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -6719.623% |
| Verona Pharma plc | 58.84 Million USD | -866.251% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -3828.363% |
| Shattuck Labs, Inc. | 14.85 Million USD | -3726.314% |
| CervoMed Inc. | 2.59 Million USD | -21803.213% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -11564.998% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -4364.133% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -5296.792% |
| Moolec Science SA | 13.94 Million USD | -3976.999% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -24160.765% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -922.662% |
| AnaptysBio, Inc. | 364.28 Million USD | -56.073% |
| Design Therapeutics, Inc. | 11.95 Million USD | -4655.37% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -4382.435% |
| NeurAxis, Inc. | 1.91 Million USD | -29624.495% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -1360.522% |
| Lumos Pharma, Inc. | 13.33 Million USD | -4164.247% |
| Achilles Therapeutics plc | 19.08 Million USD | -2878.739% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -3828.363% |
| 180 Life Sciences Corp. | 5.38 Million USD | -10453.739% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -2310.345% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2398.061% |
| Nutriband Inc. | 1.07 Million USD | -52596.449% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1758.135% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -3818.076% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -41.687% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1650.845% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -4257.022% |
| Palisade Bio, Inc. | 2.73 Million USD | -20657.649% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -10723.377% |
| Beam Therapeutics Inc. | 478.38 Million USD | -18.848% |
| Neurogene Inc. | 36.54 Million USD | -1455.588% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -42.87% |
| AEON Biopharma, Inc. | 159.88 Million USD | -255.592% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -1093.184% |
| Sesen Bio, Inc. | 30.98 Million USD | -1734.986% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -2090.023% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -7378.767% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -190.466% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -196.033% |
| Athira Pharma, Inc. | 30.05 Million USD | -1791.579% |
| Vaccinex, Inc. | 5.94 Million USD | -9468.361% |
| HCW Biologics Inc. | 15.05 Million USD | -3677.266% |
| XOMA Corporation | 145.58 Million USD | -290.543% |
| Nektar Therapeutics | 267.04 Million USD | -112.904% |
| Arvinas, Inc. | 644.6 Million USD | 11.798% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3106.157% |
| Merus N.V. | 102.15 Million USD | -456.58% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -288.488% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -497.721% |
| Rezolute, Inc. | 11.73 Million USD | -4745.338% |
| Clene Inc. | 38.95 Million USD | -1359.66% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -19867.549% |
| BeyondSpring Inc. | 48.26 Million USD | -1077.882% |
| Synlogic, Inc. | 32.89 Million USD | -1628.384% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -3790.727% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -34695.104% |
| Peak Bio, Inc. | 20.75 Million USD | -2639.565% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -795.936% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1331.616% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -50.952% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -471.013% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -131288.454% |
| MannKind Corporation | 721.36 Million USD | 21.184% |
| Ikena Oncology, Inc. | 22.33 Million USD | -2445.565% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -27155.609% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -454.198% |
| Gossamer Bio, Inc. | 249.14 Million USD | -128.199% |
| CohBar, Inc. | 1.03 Million USD | -54904.944% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -5219.038% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2884.838% |
| Legend Biotech Corporation | 589.93 Million USD | 3.624% |
| Mural Oncology plc | 37.92 Million USD | -1399.03% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -328.656% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -24669.924% |
| Disc Medicine, Inc. | 22.87 Million USD | -2385.473% |
| Champions Oncology, Inc. | 28.03 Million USD | -1928.008% |
| REGENXBIO Inc. | 262.22 Million USD | -116.816% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -16824.454% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -4436.078% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -4132.935% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -2581.217% |
| Vaxart, Inc. | 34.02 Million USD | -1570.983% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -2688.487% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1892.69% |
| Cellectis S.A. | 249.57 Million USD | -127.808% |
| Longeveron Inc. | 5.33 Million USD | -10553.026% |
| Repare Therapeutics Inc. | 41.81 Million USD | -1259.554% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 76.362% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -841.81% |
| Revolution Medicines, Inc. | 262.39 Million USD | -116.676% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -26883.958% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -6491.143% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -4717.829% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -3948.651% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -26331.985% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 88.96% |
| Denali Therapeutics Inc. | 122.96 Million USD | -362.376% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -10116.762% |
| Veru Inc. | 32.81 Million USD | -1632.719% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -8177.071% |
| Cingulate Inc. | 10.36 Million USD | -5387.495% |
| Passage Bio, Inc. | 39.26 Million USD | -1348.097% |
| Context Therapeutics Inc. | 4.19 Million USD | -13463.708% |
| Exicure, Inc. | 8.54 Million USD | -6550.509% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1826.772% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -5322.01% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -2479.52% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -248.835% |
| Nuvalent, Inc. | 31.82 Million USD | -1686.607% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -8837.211% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -802.148% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -3058.622% |
| OmniAb, Inc. | 87.4 Million USD | -550.517% |
| Anew Medical, Inc. | 8.24 Million USD | -6798.397% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -1384.893% |
| Lipocine Inc. | 2.63 Million USD | -21504.565% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -2064.099% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1313.886% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2034.059% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -559.925% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -10426.791% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -587.097% |
| Ocugen, Inc. | 23.98 Million USD | -2270.646% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -1125.143% |
| Q32 Bio Inc. | 233.12 Million USD | -143.88% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -6171.255% |
| Alumis Inc. Common Stock | 53.5 Million USD | -962.674% |
| Equillium, Inc. | 27.95 Million USD | -1933.666% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -175.205% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -10004.6% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -9170.422% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -261.385% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -718.85% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -5600.226% |
| Dominari Holdings Inc. | 4.63 Million USD | -12166.494% |
| Edesa Biotech, Inc. | 1.84 Million USD | -30772.099% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1822.928% |
| Bio-Techne Corporation | 744.34 Million USD | 23.617% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -350.877% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -65.058% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -1301.237% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1863.435% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -515.583% |
| Nkarta, Inc. | 105.6 Million USD | -438.402% |
| BioCardia, Inc. | 4.59 Million USD | -12286.754% |
| Iterum Therapeutics plc | 32.66 Million USD | -1640.714% |